Enabling the Real World Impact of Health Innovation
AVEX Impact is the nonprofit arm of AEVOLVE AG, a project designed to accelerate the pace of innovation in the health space. AVEX Impact was designed to nurture a spirit of community, participation, and purpose—to further the objectives and reach of AEVOLVE AG’s supported technologies.
As the COVID-19 pandemic continues to deepen its effect on the world’s health and economic climate, the AVEX Impact as a nonprofit organization is playing a major role in ensuring that the innovations in health technology are within reach of those who need it most, instituting programs of relevance that benefit both promising COVID-19 medical solutions and patients.
Our launch project is a strategic program with American Dream Present, Sterling Promotions and J3G Global. We are jointly developing a new platform that merges premium entertainment and world-class boxing events managed by industry icons with the novel financing models made possible by AEVOLVE.
Our Impact Goal in 2020 is to create new opportunities that expand support for health solutions and medical research initiatives through nonprofit and philanthropic efforts.
NuCISION’s technology proposes a new antiviral model that opens up a new approach towards beating the virus. It is developing a novel cell-penetrating programmable enzyme-based anti-viral model to directly address SARS-CoV-2.
This new medical technology, which is a departure from antibody or vaccine approaches, is expected to enter human trials by Q4 2021.